Phase II Trial of Weekly Docetaxel, Vinorelbine, and Trastuzumab in the First-Line Treatment of Patients with HER2-Positive Metastatic Breast Cancer
Keyword(s):
Phase Ii
◽
2012 ◽
2007 ◽
Vol 5
(4)
◽
pp. 221-222